Natco Pharma is currently trading at Rs. 645.30, up by 5.00 points or 0.78% from its previous closing of Rs 640.30 on the BSE.
The scrip opened at Rs. 649.00 and has touched a high and low of Rs. 649.00 and Rs. 640.60 respectively. So far 5769 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 654.00 on 16-Aug-2016 and a 52 week low of Rs. 382.20 on 24-Aug-2015.
Last one week high and low of the scrip stood at Rs. 654.00 and Rs. 619.00 respectively. The current market cap of the company is Rs. 11212.47 crore.
The promoters holding in the company stood at 51.28%, while Institutions and Non-Institutions held 26.01% and 22.70% respectively.
Natco Pharma has received successful Establishment Inspection Report (EIR) during the period February 29 to March 7, 2016 from the U.S. Food and Drug Administration (USFDA) for the inspection conducted at its drug manufacturing facility in Kothur Village, Mahaboob Nagar District, India. The Kothur facility predominantly caters to regulated international markets, including USA.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.